Tags:BioTechDevelopmentDrugHealthHumanIndustryInformationResearch
AN2 Therapeutics, Inc. is a biopharmaceutical company dedicated to developing therapies to treat rare, chronic, and serious infectious diseases in areas of high unmet needs. Founded by a team of experienced industry leaders in infectious disease drug research and development and boron chemistry, we have a passion for addressing the challenges of infectious disease and improving global human health. For more information, please visit www.an2therapeutics.com.
Location: United States, California, Menlo Park
Member count: 11-50
Total raised: $161M
Founded date: 2019

Investors 2

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
07.01.2022Series B$80M-finsmes.co...
21.11.2019Series A$12M-finsmes.co...
--$69M-medcitynew...

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
07.01.2022AN2 Therap...AN2 Therapeutics, Inc., a Menl...USA-finsmes.co...
21.11.2019AN2 Therap...AN2 Therapeutics, Inc., a Menl...USA-finsmes.co...
-AN2 Therap...Economic concerns have halted ...--medcitynew...